Side-by-side comparison of AI visibility scores, market position, and capabilities
World's largest online learning platform with 148M learners; university-partnered courses and professional certificates from Stanford, Google, and IBM competing with edX and LinkedIn Learning.
Coursera is the world's largest online learning platform providing university-level courses, professional certificates, and degree programs from leading institutions including Stanford, University of Michigan, Google, IBM, and Meta — offering accessible, credentialed learning at a fraction of traditional university tuition. Listed on NYSE (NYSE: COUR) and headquartered in Mountain View, California, Coursera generates approximately $700 million in annual revenue and has enrolled over 148 million learners globally since its founding in 2012 by Stanford professors Andrew Ng and Daphne Koller.\n\nCoursera's platform spans individual courses (often free to audit, paid for certificates), Specializations (multi-course sequences from universities and companies), Professional Certificates (industry-recognized credentials for in-demand skills like Google Data Analytics, IBM Data Science, Meta Front-End Developer), and full online bachelor's and master's degrees from university partners. The Coursera for Business product provides employee learning and development platforms for enterprises, and Coursera for Campus serves universities managing student learning.\n\nIn 2025, Coursera competes with edX (2U), LinkedIn Learning, Udemy, and Pluralsight for online learning market share, and competes indirectly with traditional universities for degree-seeking learners. The online learning market has seen growth in employer-sponsored and career-transition learning while the overall higher education market faces enrollment pressure. Coursera's 2025 strategy focuses on generative AI learning content (courses on AI tools are among its fastest-growing categories), expanding its degree portfolio with lower-cost university partner programs, and growing Coursera for Business enterprise contracts as companies invest in AI upskilling for their workforces.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.